`

Xintela AB

Biotechnology Research

Specialities :
Alpha 10 marker technology
Regenerative medicine
And cancer
revenue-icon Revenue
< 1M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About Xintela AB

What does Xintela ab do?+

Xintela develops medical products in stem cell therapy and targeted cancer therapy based on the Companys cell surface marker integrin 101 which is found on mesenchymal stem cells and on certain aggressive cancer cells. The stem cell marker is used to select and quality-assure the patent-protected stem cell product XSTEM, which is in clinical development for treatment of knee osteoarthritis and difficult-to-heal leg ulcers. The company produces XSTEM for the clinical studies in its GMP-approved manufacturing facility. In cancer therapy, which is run by the wholly owned subsidiary Targinta AB, therapeutic antibodies, targeting integrin 101 (First-in-Class) are being developed for...

What are Xintela ab's specialties? +

Alpha 10 marker technology,regenerative medicine,and cancer

What is Xintela ab's industry? +

Xintela ab operates in the Biotechnology research industry.

What is Xintela ab's revenue? +

Xintela ab's revenue is < 1m

What is Xintela ab's company size? +

Xintela ab has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.